Youssef Hijazi is an expert in pharmacokinetics and pharmacodynamics. He is currently working in the field of Therapeutic proteins and antibodies, at Sanofi-Aventis R&D in Frankfurt. He is a pharmacist by training and holds a PhD degree in pharmacokinetics from Claude Bernard University of Lyon. Youssef Hijazi has about 15 years of experience in the pharma industry, worked previously for Roche, Novartis, and Amgen and for other small biotech. companies. His areas of expertise include preclinical development, Clinical pharmacology, and DMPK. He is trained in PKPD data analysis, PKPD interpretation and model based human dose prediction. He contributed to development of Blinatumomab as well as many other drug candidates. As a member of international R&D project teams, he has been working on different therapeutic modality in multiple disease areas such as immunology, oncology and Diabetes.